Alpaslan KILIÇARSLAN, Alma CENOLİ ASLAN, Gamze GEZGEN

The role of vitamin D deficiency in parathyroid hormone levels

Vitamin D deficiency is an important cause of secondary hyperparathyroidism. We aimed to investigate the effect of vitamin D levels on parathyroid hormone (PTH) levels. Materials and methods: We retrospectively chose 2226 patients who were admitted to our hospital’s general internal medicine department for various reasons and had both PTH and vitamin D tests on the same day. Results: It was found that 22.3% of the patients had high levels of PTH and 92% of them had secondary hyperparathyroidism. The average vitamin D level was 16.4 ng/mL. The vitamin D levels of 64% of the patients were below 20 ng/mL (n = 1417), and those of the rest of the patients were above 20 ng/mL (n = 809). Of the patients with vitamin D deficiency (

Anahtar Kelimeler:

Key words: Vitamin D deficiency, high parathyroid hormone levels, secondary hyperparathyroidism

The role of vitamin D deficiency in parathyroid hormone levels

Keywords:

Key words: Vitamin D deficiency, high parathyroid hormone levels, secondary hyperparathyroidism,

PDF

___

McCabe MP, Smyth MP, Richardson DR. Current concept
review: vitamin D and stress fractures. Foot Ankle Int 2012; 33: 526–33. 6.
Mehrdad S, Samane T, Zahra N. The optimal dose of vitamin
D in growing girls during academic years: a randomized trial.
Turk J Med Sci 2011; 41: 33–37. 7.
Bischoff-Ferrari H. Vitamin D: What is an adequate vitamin D
level and how much supplementation is necessary? Best Pract
Res Clin Rheumatol 2009; 23: 789–95. 8. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998; 351: 805–6. 9. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis Int 1997; 7: 439–43.
Holick MF. Vitamin D deficiency: what a pain it is. Mayo Clin Proc 2003; 78: 1457–59.
Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003; 78: 1463–70.
Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777–83.
Chan YL, McKay C, Dye E, Slatopolsky E. The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells. Calcif Tissue Int 1986; 38: 27–32.
Goltzman D, Miao D, Panda DK, Hendy GN. Effects of calcium and of the Vitamin D system on skeletal and calcium homeostasis: lessons from genetic models. J Steroid Biochem Mol Biol 2004; 89–90: 485–9.
Naveh-Many T, Silver J. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Clin Invest 1990; 86: 1313–9.
Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008; 87: 1080–6.
Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 2002; 75: 611–5.
Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf) 2005; 62: 265–81.
Reginster JY. The high prevalence of inadequate serum vitamin D levels and implications for bone health. Curr Med Res Opin 2005; 21: 579–86.
Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89: 552–72.
Bordelon P, Ghetu MV, Langan RC. Recognition and management of vitamin D deficiency. Am Fam Physician 2009; 80: 841–6.
Karadağ AS, Ertuğrul DT, Tutal E, Akın KO. The role of anemia and vitamin D levels in acute and chronic telogen effluvium. Turk J Med Sci 2011; 41: 827–33.
Pilz S, Kienreich K, Tomaschitz A, Lerchbaum E, Meinitzer A, März W et al. Vitamin D and cardiovascular disease: update and outlook. Scand J Clin Lab Invest Suppl 2012; 243: 83–91.
Holick MF. Vitamin D: A millennium perspective. J Cell Biochem. 2003; 88: 296–307.
Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002; 359: 1761–7.
Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477–501.